Page last updated: 2024-10-31

mirtazapine and Triple Negative Breast Neoplasms

mirtazapine has been researched along with Triple Negative Breast Neoplasms in 1 studies

Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.

Triple Negative Breast Neoplasms: Breast neoplasms that do not express ESTROGEN RECEPTORS; PROGESTERONE RECEPTORS; and do not overexpress the NEU RECEPTOR/HER-2 PROTO-ONCOGENE PROTEIN.

Research Excerpts

ExcerptRelevanceReference
"Pruritus is a debilitating symptom that can be associated with cutaneous involvement by an underlying malignancy."5.43Effective use of mirtazapine for refractory pruritus associated with carcinoma en cuirasse. ( Carlberg, VM; Girouard, SD; Lee, JJ; Mostaghimi, A, 2016)
"Pruritus is a debilitating symptom that can be associated with cutaneous involvement by an underlying malignancy."1.43Effective use of mirtazapine for refractory pruritus associated with carcinoma en cuirasse. ( Carlberg, VM; Girouard, SD; Lee, JJ; Mostaghimi, A, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lee, JJ1
Girouard, SD1
Carlberg, VM1
Mostaghimi, A1

Other Studies

1 other study available for mirtazapine and Triple Negative Breast Neoplasms

ArticleYear
Effective use of mirtazapine for refractory pruritus associated with carcinoma en cuirasse.
    BMJ supportive & palliative care, 2016, Volume: 6, Issue:1

    Topics: Aged; Antidepressive Agents, Tricyclic; Antipruritics; Carcinoma, Ductal, Breast; Female; Histamine

2016